These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 14972469

  • 1. Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer.
    Kurokawa K, Ito K, Yamamoto T, Takechi H, Miyamoto S, Suzuki K, Yamanaka H.
    Urology; 2004 Feb; 63(2):268-72. PubMed ID: 14972469
    [Abstract] [Full Text] [Related]

  • 2. Is additional testing necessary in men with prostate-specific antigen levels of 1.0 ng/mL or less in a population-based screening setting? (ERSPC, section Rotterdam).
    Roobol MJ, Roobol DW, Schröder FH.
    Urology; 2005 Feb; 65(2):343-6. PubMed ID: 15708050
    [Abstract] [Full Text] [Related]

  • 3. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
    Ito K, Raaijmakers R, Roobol M, Wildhagen M, Yamanaka H, Schröder FH.
    Cancer; 2005 Jan 15; 103(2):242-50. PubMed ID: 15578715
    [Abstract] [Full Text] [Related]

  • 4. Incidental prostate cancer in radical cystoprostatectomy specimens.
    Jin XD, Chen ZD, Wang B, Cai SL, Yao XL, Jin BY.
    Asian J Androl; 2008 Sep 15; 10(5):809-14. PubMed ID: 18645685
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer.
    Ellis WJ, Etzioni R, Vessella RL, Hu C, Goodman GE.
    J Urol; 2001 Jul 15; 166(1):93-8; discussion 98-9. PubMed ID: 11435831
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Radical retropubic prostatectomy in men younger than 45 years diagnosed during early prostate cancer detection program.
    Varkarakis J, Pinggera GM, Sebe P, Berger A, Bartsch G, Horninger W.
    Urology; 2004 Feb 15; 63(2):337-41. PubMed ID: 14972485
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Prostate cancer screening using prostate-specific antigen (PSA) determinations in plasma. National Academy of Medicine].
    Bourel M, Ardaillou R, Académie nationale de médecine.
    Bull Acad Natl Med; 2003 Feb 15; 187(5):985-95. PubMed ID: 14979060
    [Abstract] [Full Text] [Related]

  • 12. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME.
    Clin Lab Sci; 2001 Feb 15; 14(2):102-7. PubMed ID: 15625982
    [Abstract] [Full Text] [Related]

  • 13. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I, Weiss NS, Lin DW, Stanford JL.
    Cancer Causes Control; 2007 Nov 15; 18(9):931-7. PubMed ID: 17641982
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.
    Raaijmakers R, Wildhagen MF, Ito K, Pàez A, de Vries SH, Roobol MJ, Schröder FH.
    Urology; 2004 Feb 15; 63(2):316-20. PubMed ID: 14972481
    [Abstract] [Full Text] [Related]

  • 18. Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/mL and abnormal digital rectal examination findings.
    Luciani LG, De Giorgi G, Valotto C, Zanin M, Bierti S, Zattoni F.
    Urology; 2006 Mar 15; 67(3):555-8. PubMed ID: 16527579
    [Abstract] [Full Text] [Related]

  • 19. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
    Price MM, Hamilton RJ, Robertson CN, Butts MC, Freedland SJ.
    Urology; 2008 May 15; 71(5):787-91. PubMed ID: 18267334
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.